ICON plc (ICLR) Insider Trading

Last 12 months

Insiders sold $4.04M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Ronan Martin Murphy sold $876k on Sep 17, 57% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market

−$4.04M

0 buys · 12 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 9

executives and directors

Last open-market buy

None

in the last two years

Get an email when ICLR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 17	Eugene Pacelli McCague Director	SoldNo plan	3,255	$175.00	$570k	46%	Form 4
Sep 17	Ronan Martin Murphy Director	SoldNo plan	5,005	$175.00	$876k	57%	Form 4
Sep 16	John Dr Climax Director	SoldNo plan	5,005	$175.00	$876k	71%	Form 4
Aug 11	Anne Clem Whitaker Director	SoldNo plan 4 parts	841	$164.29 average	$138k	49%	Form 4
Aug 11	Julie O'Neill Director	SoldNo plan 4 parts	915	$164.29 average	$150k	21%	Form 4
Aug 11	Ciaran Murray Director	SoldNo plan 4 parts	2,677	$164.29 average	$440k	12%	Form 4
Aug 11	Ronan Martin Murphy Director	SoldNo plan 4 parts	841	$164.29 average	$138k	18%	Form 4
Aug 11	Eugene Pacelli McCague Director	SoldNo plan 4 parts	841	$164.29 average	$138k	18%	Form 4
Aug 11	Linda Grais Director	SoldNo plan 4 parts	841	$164.29 average	$138k	12%	Form 4
Aug 11	John Dr Climax Director	SoldNo plan 4 parts	841	$164.29 average	$138k	29%	Form 4
Aug 11	Nigel Bernard John Clerkin Chief Financial Officer	SoldNo plan 4 parts	2,267	$164.29 average	$372k	28%	Form 4
Aug 10	Barry Edward Balfe Chief Executive Officer	SoldNo plan 2 parts	382	$164.07 average	$63k	7.4%	Form 4

Sep 17No plan
Eugene Pacelli McCague
Director · sold 3,255 at $175.00
$570k
46% of stake
Sep 17No plan
Ronan Martin Murphy
Director · sold 5,005 at $175.00
$876k
57% of stake
Sep 16No plan
John Dr Climax
Director · sold 5,005 at $175.00
$876k
71% of stake
Aug 11No plan
Anne Clem Whitaker
Director · sold 841 at avg $164.29
$138k
49% of stake
Aug 11No plan
Julie O'Neill
Director · sold 915 at avg $164.29
$150k
21% of stake
Aug 11No plan
Ciaran Murray
Director · sold 2,677 at avg $164.29
$440k
12% of stake
Aug 11No plan
Ronan Martin Murphy
Director · sold 841 at avg $164.29
$138k
18% of stake
Aug 11No plan
Eugene Pacelli McCague
Director · sold 841 at avg $164.29
$138k
18% of stake
Aug 11No plan
Linda Grais
Director · sold 841 at avg $164.29
$138k
12% of stake
Aug 11No plan
John Dr Climax
Director · sold 841 at avg $164.29
$138k
29% of stake
Aug 11No plan
Nigel Bernard John Clerkin
Chief Financial Officer · sold 2,267 at avg $164.29
$372k
28% of stake
Aug 10No plan
Barry Edward Balfe
Chief Executive Officer · sold 382 at avg $164.07
$63k
7.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ICLR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Diagnostics & Research

LONN.XSWXLonza Group AG

SNNSmith & Nephew plc Sponsored ADR

ALCE.XSWXAlcon N 2.Linie

ALCAlcon Inc.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ICLR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.